Interleukin-6 Receptor Antagonist [EPC]

90674 reported adverse events

Drugs of this class: SARILUMAB TOCILIZUMAB

These side effects are most commonly reported by patients taking drugs of the Interleukin-6 Receptor Antagonist [EPC] class:

# Side effect Count
0 DRUG INEFFECTIVE 31167
1 RHEUMATOID ARTHRITIS 18629
2 PAIN 15930
3 ARTHRALGIA 13129
4 OFF LABEL USE 12908
5 JOINT SWELLING 12035
6 FATIGUE 11108
7 DRUG INTOLERANCE 10167
8 RASH 9881
9 CONTRAINDICATED PRODUCT ADMINISTERED 9406
See all common reactions for Interleukin-6 Receptor Antagonist [EPC]

Drugs of the Interleukin-6 Receptor Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HUMAN ANTICHIMERIC ANTIBODY POSITIVE 275 0.9291
1 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 3271 0.9089
2 SWOLLEN JOINT COUNT INCREASED 765 0.8875
3 DISABILITY ASSESSMENT SCALE SCORE INCREASED 212 0.8689
4 RHEUMATOID FACTOR POSITIVE 2656 0.8167
5 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 142 0.8161
6 RED BLOOD CELL SEDIMENTATION RATE 203 0.8153
7 PEMPHIGUS 5941 0.7916
8 RHEUMATOID FACTOR NEGATIVE 133 0.7778
9 RHEUMATIC FEVER 934 0.7694
See all enriched reactions for Interleukin-6 Receptor Antagonist [EPC]